Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emerging therapies for melanoma.

Literature DB >> 18402522

Emerging therapies for melanoma.

Rajini Katipamula¹, Svetomir N Markovic.

Abstract

Substantial progress has been made in understanding the pathogenesis of malignant melanoma at the cellular level, leading to the development of several new agents in the treatment of melanoma. The focus of this review is to summarize the emerging therapies and investigational agents in the treatment of melanoma over the last 5 years.

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 18402522 DOI： 10.1586/14737140.8.4.553

Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN： 1473-7140 Impact factor: 4.512

Keyword Cloud
Cited

9 in total

Review 1. Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.

Authors: Gajanan S Inamdar; SubbaRao V Madhunapantula; Gavin P Robertson
Journal: Biochem Pharmacol Date: 2010-05-09 Impact factor: 5.858

2. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4.

Authors: Natalie Nguyen; Arati Sharma; Nhung Nguyen; Arun K Sharma; Dhimant Desai; Sung Jin Huh; Shantu Amin; Craig Meyers; Gavin P Robertson
Journal: Cancer Prev Res (Phila) Date: 2010-11-19

3. Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.

Authors: Lucia Jilaveanu; Christopher Zito; Sandra J Lee; Katherine L Nathanson; Robert L Camp; David L Rimm; Keith T Flaherty; Harriet M Kluger
Journal: Clin Cancer Res Date: 2009-02-01 Impact factor: 12.531

4. The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo.

Authors: Raúl Ortiz; Jose Prados; Consolacion Melguizo; Ana R Rama; Ana Segura; Fernando Rodríguez-Serrano; Houria Boulaiz; Fidel Hita; Antonio Martinez-Amat; Roberto Madeddu; Juan L Ramos; Antonia Aranega
Journal: J Mol Med (Berl) Date: 2009-07-05 Impact factor: 4.599

Emerging therapies for melanoma.

Review 1. Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.

2. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4.

3. Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.

4. The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo.

5. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates.

6. Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.

7. Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.

Review 8. Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.

Review 9. Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanoma.